| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Oruka Therapeutics, Inc. | Chief Operating Officer | Common Stock | 237,584 | $7,201,171 | $30.31 | 23 Jan 2026 | Direct |
| Oruka Therapeutics, Inc. | Chief Operating Officer | Employee Stock Option (right to buy) | 130,000 | 23 Jan 2026 | Direct | ||
| Oruka Therapeutics, Inc. | Chief Operating Officer | Employee Warrant (right to buy) | 94,996 | 02 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | 23 Jan 2026 | 2 | $0 | 4 | Chief Operating Officer | 23 Jan 2026, 17:40 |
| ORKA | Oruka Therapeutics, Inc. | 02 Jan 2026 | 5 | -$331,795 | 4 | Chief Operating Officer | 02 Jan 2026, 20:25 |
| ORKA | Oruka Therapeutics, Inc. | 01 Jul 2025 | 1 | $0 | 4 | Chief Operating Officer | 01 Jul 2025, 21:26 |
| ORKA | Oruka Therapeutics, Inc. | 01 Jul 2025 | 0 | $0 | 3 | Chief Operating Officer | 01 Jul 2025, 21:21 |